Kepler Cheuvreux

MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale

Retrieved on: 
Friday, April 5, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Research report, Patient, Target price, Target, MET, Survival, Cancer, Kepler Cheuvreux, Fine chemical

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, announces the initiation of coverage of its stock by Gilbert Dupont.

Key Points: 
  • MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, announces the initiation of coverage of its stock by Gilbert Dupont.
  • With a research report named “Echec et MaaT”, Gilbert Dupont / Groupe Société Générale initiated coverage of MaaT Pharma on April 4th, 2024 with a Buy recommendation and a Target Price of 16 Euros.
  • This new coverage strengthens the visibility of MaaT Pharma among French and international institutional investors and adds to the ongoing coverage by the brokerage firms, Kepler Cheuvreux, KBC Securities, Kempen and Portzamparc/Groupe BNP Paribas.

Anima Alternative SGR Deploys Kepler Cheuvreux Analytics Suite via FlexTRADER EMS

Retrieved on: 
Thursday, January 11, 2024
Professional Services, Technology, Data Analytics, Finance, Software, Fintech, Capital punishment, API, Intelligence, Anima, Digital, Kepler Cheuvreux, EMS, Automation

FlexTrade Systems ( @FlexTrade ), a global leader in multi-asset execution and order management systems, and Kepler Cheuvreux (KCx), a leading independent broker, today announced Anima Alternative SGR is live and in production using KCx's new suite of intra-day stock-specific dynamic forecasts and analytics via API.

Key Points: 
  • FlexTrade Systems ( @FlexTrade ), a global leader in multi-asset execution and order management systems, and Kepler Cheuvreux (KCx), a leading independent broker, today announced Anima Alternative SGR is live and in production using KCx's new suite of intra-day stock-specific dynamic forecasts and analytics via API.
  • Additionally, with the analytics available within the FlexTRADER EMS order blotter, in combination with FlexAlgoWheel, sophisticated dynamic and arrival rules can be applied by traders using drag-and-drop functionality to automate low-touch orders.
  • Brian Corcoran, Head of Trading at Anima Alternative, stated: “We are delighted to be one of the first firms to adopt KCx's new analytics suite via our EMS solution, FlexTRADER EMS.
  • Offerings like KCx’s new analytical suite are a perfect match for FlexTRADER EMS.

Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.

Retrieved on: 
Thursday, December 14, 2023
Ukrsibbank BNP Paribas Group, ISIN, China Investment Securities, Regulatory News Service, Medtech, BNP Paribas, Wealth, Aix-en-Provence, Kepler Cheuvreux, Security (finance), Portzamparc

Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.

Key Points: 
  • Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.
  • Aix-en-Provence, November 27, 2023 – 7:30 am CEST- Affluent Medical (ISIN code: FR0013333077 – ticker: AFME), a French clinical-stage MedTech company specializing in the international development and industrialization of innovative medical prostheses, announces today that Portzamparc - Groupe BNP Paribas has initiated coverage of its stock.
  • Portzamparc - BNP Paribas Group began covering the stock with a study entitled "Au plus proche de votre coeur" ("Closer to your heart"), published on November 24, 2023.
  • This initiation completes the coverage of Affluent Medical’s stock and adds to the financial analyst consensus alongside Invest Securities and Kepler Cheuvreux.

ABC arbitrage : Continuation of liquidity contract of ABC ARBITRAGE

Retrieved on: 
Tuesday, September 26, 2023
ARBITRAGE, Kepler, AMF, ABC, Kepler Cheuvreux, Cryptocurrency, Sales, Security (finance)

ABC ARBITRAGE informs that it will continue the liquidity contract with Kepler Cheuvreux, adding the following additional resources:

Key Points: 
  • ABC ARBITRAGE informs that it will continue the liquidity contract with Kepler Cheuvreux, adding the following additional resources:
    • the following resources appeared on the last half year statement on 30 June 2023 on the liquidity account:
    - Number of executions on buy side on semester: 783
    - Number of executions on sell side on semester: 1,120
    - Traded volume on buy side on semester: 125,924 shares for € 781,516.85
    - Traded volume on sell side on semester: 115,527 shares for € 719,846.14
    • the following resources appeared on the liquidity account when the activity started:
    The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

Affluent Medical : Increase in resources allocated to the liquidity contract with Kepler Cheuvreux.

Retrieved on: 
Monday, July 10, 2023
Kepler, Regulatory News Service, ISIN, AMF, Pathology, Aix-en-Provence, Medtech, Urinary incontinence, Kepler Cheuvreux, Medical device

Affluent Medical : Increase in resources allocated to the liquidity contract with Kepler Cheuvreux.

Key Points: 
  • Affluent Medical : Increase in resources allocated to the liquidity contract with Kepler Cheuvreux.
  • Aix-en-Provence, July 10, 2023 - 5:30 pm CET- Affluent Medical (ISIN code: FR0013333077 – ticker: AFME), a French MedTech specializing in the international development and industrialization of innovative medical prostheses, at a clinical stage, to treat mitral heart valve pathology and urinary incontinence, today announced an increase in the resources allocated to the liquidity contract entered into with Kepler Cheuvreux, with the aim of improving the liquidity of the share.
  • 2021-01 of June 22, 2021 (the "AMF Decision"), Affluent Medical today increased the resources allocated to the liquidity contract with Kepler Cheuvreux by 35,000 euros.
  • Following this increase in the cash amount allocated to the liquidity contract, the available resources are as follows:

First Sentier Investors appoints Sudip Hazra Director of the First Sentier MUFG Sustainable Investment Institute

Retrieved on: 
Thursday, June 29, 2023
Kepler, Kepler Cheuvreux, Socially responsible investing, Turner, MUFG, Mitsubishi UFJ Trust and Banking Corporation, FSI, Research, Mitsubishi Group, Article, Johannes Kepler, Hazra, First Sentier Investors, Mitsubishi UFJ Financial Group, Knowledge, ESG, Sudip Chattopadhyay, Renewable energy, Invesco

NEW YORK and LONDON, June 29, 2023 /PRNewswire/ -- First Sentier Investors (FSI), a leading global investment manager, today announced the appointment of Sudip Hazra as Director of the First Sentier MUFG Sustainable Investment Institute (the Institute), effective June 6.

Key Points: 
  • NEW YORK and LONDON, June 29, 2023 /PRNewswire/ -- First Sentier Investors (FSI), a leading global investment manager, today announced the appointment of Sudip Hazra as Director of the First Sentier MUFG Sustainable Investment Institute (the Institute), effective June 6.
  • The Institute is jointly supported by FSI and its shareholder, Mitsubishi UFJ Trust and Banking Corporation, a subsidiary of Mitsubishi UFJ Financial Group (MUFG).
  • Turner added, "As responsible investors, we believe that incorporating ESG considerations into our investment approach leads to better outcomes for our clients and broader society.
  • Hazra, who is based in London, brings a wealth of sustainable research experience to his new role.

MGI - Media and Games Invest SE Changes Liquidity Provider to Kepler Cheuvreux

Retrieved on: 
Thursday, June 15, 2023
Kepler, ISIN, Person, MGI, Kepler Cheuvreux, Auction

Stockholm, June 14, 2023: MGI – Media and Games Invest SE (“MGI” or the “Company”, ISIN: SE0018538068; Ticker M8G; Nasdaq First North Premier Growth Market and Scale Segment Frankfurt Stock Exchange) has signed a liquidity provider agreement with Kepler Cheuvreux effective August 1, 2023.

Key Points: 
  • Stockholm, June 14, 2023: MGI – Media and Games Invest SE (“MGI” or the “Company”, ISIN: SE0018538068; Ticker M8G; Nasdaq First North Premier Growth Market and Scale Segment Frankfurt Stock Exchange) has signed a liquidity provider agreement with Kepler Cheuvreux effective August 1, 2023.
  • In its assignment as liquidity provider, Kepler Cheuvreux will trade in the Company's shares by continuously placing trading orders on the buy and sell side in the order book.
  • The purpose of the liquidity provider is to improve the liquidity of the Company's share and reduce the spread between the bid and ask price during ongoing trading.
  • Pareto Securities AB is currently acting as liquidity provider for the Company and will, up until September 1, 2023, continue to act as a liquidity provider for MGI.

MaaT Pharma Announces Initiation of Coverage of its Stock by Kepler Cheuvreux

Retrieved on: 
Friday, January 27, 2023
Biotechnology, Finance, Health, Professional Services, Clinical Trials, Kepler, MET, Kepler Cheuvreux, Maat, Research report, Patient, Cancer, Survival, Pharmaceutical industry

MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announces the initiation of coverage of its stock by Kepler Cheuvreux.

Key Points: 
  • MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announces the initiation of coverage of its stock by Kepler Cheuvreux.
  • With a research report named “The Microbiome revolution”, Kepler Cheuvreux today initiates coverage of MaaT Pharma with a Buy recommendation.
  • This new coverage strengthens the visibility of MaaT Pharma’s share among French and international institutional investors and is in addition to those already carried out by the brokerage firms KBC Securities, Kempen and Portzamparc/Groupe BNP Paribas.

Asset Management Strategy Advisor Indefi Promotes Clémence Droin to Partner

Retrieved on: 
Wednesday, February 1, 2023
Kepler, University of Vienna, Kepler Cheuvreux, Business, Economics, Corporate finance, GP, Consultant, Partnership, Paris Dauphine University, Construction, Financial services

PARIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Indefi , a leading strategy advisor for asset managers worldwide, today announced it has appointed Clémence Droin to partner, effective immediately.

Key Points: 
  • PARIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Indefi , a leading strategy advisor for asset managers worldwide, today announced it has appointed Clémence Droin to partner, effective immediately.
  • Previously, Droin was a senior engagement manager at the firm and was instrumental in furthering Indefi’s ongoing work with asset managers and private asset platforms.
  • “From the beginning of her tenure at Indefi, Clémence has demonstrated a keen eye for overarching trends crucial to our clients’ strategic growth plans, as well as the cutting-edge initiatives they may be overlooking,” said Richard Bruyère, managing partner of Indefi.
  • Indefi currently has more than 80 strategy consultants working for asset managers and GPs, with operations spanning across Europe and the United States.

Charwood Energy: Half-year liquidity contract statement

Retrieved on: 
Thursday, February 2, 2023
Kepler, Regulatory News Service, ISIN, Kepler Cheuvreux, Security (finance)

Dissemination of a French Regulatory News, transmitted by EQS Group.

Key Points: 
  • Dissemination of a French Regulatory News, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Under the liquidity contract entered into between Charwood Energy (ISIN code: FR001400AJ60, mnémo code: ALCWE) and Kepler-Cheuvreux, the following resources appeared on the liquidity account on 31 December 2022:
    During the second half of 2022, the following have been traded: